🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED.
Not a new chemotherapy drug.
Not a breakthrough immunotherapy.
Not a billion-dollar cancer treatment.
Just one simple dosing strategy.
According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first.
And it all starts with one number.
📌 1 mg/kg/day.
Before explaining why, here's the dosing framework Dr. Makis discusses.
📊 The Four Ivermectin Dosing Ranges
🟢 Low Dose: ≤0.5 mg/kg/day
Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports.
🟡 Medium Dose: 1.0 mg/kg/day
Dr. Makis' recommended starting dose for most cancers.
🔵 High Dose: 2.0 mg/kg/day
Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers.
🔴 Very High Dose: ≥2.5 mg/kg/day
Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported.
Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention.
After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers.
According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including:
• Breast cancer
• Colon cancer
• Lung cancer
• Pancreatic cancer
• Kidney (renal cell) cancer
• Gastric cancer
• Leukemia
One exception stood out.
Lymphoma.
Dr. Makis says he has found very little published research involving Ivermectin and lymphoma.
That doesn't mean it doesn't work.
It simply means the evidence is currently limited.
❓What does 1 mg/kg/day actually look like?
For someone weighing 60 kg (132 lbs)...
That's approximately 60 mg of Ivermectin every day.
Equivalent to:
💊 Five 12 mg tablets
OR
💧 About 6 mL of liquid Ivermectin, roughly one teaspoon.
According to Dr. Makis, that's where he recommends starting for many cancers.
Can lower doses still have an effect?
✅ He believes they can.
Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie.
The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range.
📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months.
That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses.
However...
He also believes the available evidence suggests the effect is dose dependent.
In other words...
Higher doses may produce greater effects, although more clinical research is needed.
What about the most aggressive cancers?
• Pancreatic cancer
• Leukemia
• Brain cancer
For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations.
He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers.
He also discusses a case reported by Dr. Allan Landrito.
According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months.
He says her cancer eventually disappeared.
She experienced temporary visual side effects that resolved after a few days.
❓How high have reported doses gone?
According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day.
He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved.
One point Dr. Makis returns to repeatedly...
Long-term use.
He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects.
He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity.
So why aren't there larger cancer trials?
Dr. Makis believes one of the biggest obstacles is economics.
Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials.
Whether future research ultimately confirms or challenges these ideas remains to be seen.
But Dr. Makis' message is remarkably simple.
One graph.
One dosing strategy.
One starting point.
📌 1 mg/kg/day.
Because the conversation isn't just about Ivermectin anymore.
It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies.
🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer?
🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines.
💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose @rxmeds_store. Trusted by thousands of customers worldwide.
#Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds
He was never in opposition?
Self-betrayal or an unschooled prodigal son: Having failed to guard his votes in Malava like Ol Kalou did, Seth Panyako ditches DAP-K and lands back to UDA where he is expected to work with Faruk Kibet, among others
🚨BREAKING: 88.3% of doctors would REJECT chemotherapy if they got cancer themselves. Yet they push it on patients as the only “Standard of Care.”
The hard data: cytotoxic chemotherapy contributes just 2.1% to 5-year survival in adult cancers (U.S. figures). Dr. Thomas Seyfried — one of the world’s leading cancer metabolism researchers — says he would choose the Ivermectin + Fasting Protocol instead.
Why? Cancer cells are metabolically rigid. They’re addicted to glucose and can’t efficiently use ketones. Healthy cells thrive on them. A low Glucose-Ketone Index (GKI) starves the cancer while supercharging your Natural Killer cells and T-cells — the body’s own assassins.
Chemo and radiation often destroy those same immune cells, setting the stage for recurrence. This isn’t fringe theory. It’s built on Otto Warburg’s Nobel-winning work and backed by cutting-edge research (including new preclinical data on ketogenic diets enhancing targeted metabolic drugs).
The cancer-industrial complex is a multi-billion-dollar machine optimized for lifelong treatment, not eradication.
Fantastic news? The truth is finally breaking through. Metabolic therapy isn’t “alternative” anymore — it’s the logical next evolution. Would you want your oncologist to tell you this on day one of diagnosis?
Oncologist Dr. William Makis:
"Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it."
"For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer.
"In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it.
@sulackpete
"And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well.
"And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell.
Mutula Kilonzo was damn right. From his resting place, he is speaking to Kenyans. A President of President Kibaki’s caliber comes only once in a lifetime. We now know
“Two lovely friends have separated because of policing each other.”
Was Mkurugenzi Abel Mutua lecturing his friend Njugush on marriage?
Be the judge 🤣🤣
Nairobi Expressway is 27 kilometres and cost about KSh 88 billion, that’s roughly KSh 3.25 billion per kilometre ☺️☺️
And that’s a four-lane road.
Rironi - Mau Summit Road, 175 km main stretch + 58 km (Rironi–Maai Mahiu–Naivasha) is costing about KSh 187 billion.
That’s less than KSh 1 billion per kilometre. And remember, key sections like Nairobi to Naivasha will be six lanes.
But the Expressway is “good,” Mau Summit is “bad,” and Kasongo must go…
Alright 😅